Key result
VDC/IE chemotherapy yields marked tumor reduction in primary pulmonary Ewing sarcoma mimicking pulmonary embolism.
Why the study?
Primary pulmonary Ewing sarcoma is exceptionally rare and diagnostically challenging, mimicking conditions like pulmonary embolism.
Case Report (n=1)
Primary pulmonary Ewing sarcoma is an exceptionally rare condition that can mimic pulmonary embolism, requiring a high index of suspicion for accurate diagnosis and management.
Supports VDC/IE response in rare pulmonary Ewing sarcoma mimicking embolism; leaves open prospective validation before broader adoption.
While classic Ewing sarcoma targets bone, the extra-skeletal variant develops in soft tissues, with a rare incidence of 0.4 per million. Although the chest wall is a recognized site for extra-skeletal Ewing sarcoma, primary pulmonary Ewing sarcoma is exceptionally rare, representing less than 1% of all extra-skeletal Ewing sarcoma cases. An 18-year-old female experienced dyspnea, tachycardia, and cough for 5 months. After not responding to symptomatic therapy, she presented to the emergency department for acute worsening of dyspnea and tachycardia, raising clinical suspicion for pulmonary embolism. Computed tomography revealed a massive pulmonary mass and a pleural effusion. Immunostaining findings were consistent with Ewing sarcoma. She was treated with chemotherapy as per protocol VDC/IE (Vincristine, Doxorubicin, Cyclophosphamide/Ifosfamide, Etoposide). She responded well to therapy, with a marked reduction in tumor size. Pulmonary Ewing sarcoma remains a rare and diagnostically challenging condition requiring a high index of suspicion and multidisciplinary management. This case highlights the need for further research to optimize diagnostic and therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Hassan et al. (2026) conducted a case report in Primary pulmonary Ewing sarcoma (n=1). Chemotherapy (VDC/IE protocol) was evaluated on Response to therapy / tumor size reduction. Chemotherapy using the VDC/IE protocol resulted in a marked reduction in tumor size in an 18-year-old female with primary pulmonary Ewing sarcoma mimicking pulmonary embolism.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: